Search Results - Peter Ellmark

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform by Barnabas Nyesiga, Karin Hägerbrand, Laura Varas, Anette Gjörloff Wingren, Mats Ohlin, Peter Ellmark, Laura von Schantz

    Published in Drug Delivery (2025-12-01)
    Get full text
    Article


  2. 2

    First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies by Peter Ellmark, Jeffrey Yachnin, Ana Carneiro, Lena Schultz, Amanda Hahn, Sumeet Ambarkhane, Karin Enell Smith, Gustav J. Ullenhag

    Published in Journal for ImmunoTherapy of Cancer (2025-01-01)
    Get full text
    Article


  3. 3

    839 Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer by Peter Ellmark, Milad Abolhalaj, Kristina Lundberg, Karin Hägerbrand, Carl Borrebaeck, Viktor Sincic, Henrik Lilljebjörn, Alar Aab, Thoas Fioretos, Fredrik Liedberg

    Published in Journal for ImmunoTherapy of Cancer (2020-11-01)
    Article


  4. 4

    Transcriptional profiling demonstrates altered characteristics of CD8+ cytotoxic T‐cells and regulatory T‐cells in TP53‐mutated acute myeloid leukemia by Milad Abolhalaj, Viktor Sincic, Henrik Lilljebjörn, Carl Sandén, Alar Aab, Karin Hägerbrand, Peter Ellmark, Carl A. K. Borrebaeck, Thoas Fioretos, Kristina Lundberg

    Published in Cancer Medicine (2022-08-01)
    Get full text
    Article


  5. 5

    Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody by Hampus Andersson, Aastha Sobti, David Gomez Jimenez, Yago Pico de Coaña, Sumeet Vijay Ambarkhane, Karin Hägerbrand, Karin Enell Smith, Malin Lindstedt, Peter Ellmark

    Published in Cells (2023-09-01)
    Get full text
    Article


  6. 6

    858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies by Peter Ellmark, Karin Hägerbrand, Doreen Werchau, Anna Rosén, Karin Barchan, Adnan Deronic, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Lill Ljug, Mia Thageson, Christina Sakellariou

    Published in Journal for ImmunoTherapy of Cancer (2020-11-01)
    Article


  7. 7

    837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro by Malin Lindstedt, Peter Ellmark, Karin Hägerbrand, Sara Fritzell, Anette Sundstedt, David Gomez Jimenez, Anneli Nilsson, Lill Ljung, Mattias Levin, Mona Celander, Ida Uddbäck, Amulya Krishna Shetty, Hampus Andersson

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  8. 8

    Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes by Viktor Sincic, Ken F. Arlenhold, Sarah Richtmann, Henrik Lilljebjörn, Pontus Eriksson, Gottfrid Sjödahl, Mats Wokander, Karin Hägerbrand, Peter Ellmark, Thoas Fioretos, Carl A. K. Borrebaeck, Fredrik Liedberg, Kristina Lundberg

    Published in Cells (2024-05-01)
    Get full text
    Article


  9. 9

    CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation by Itziar Otano, Arantza Azpilikueta, Javier Glez-Vaz, Maite Alvarez, José Medina-Echeverz, Ivan Cortés-Domínguez, Carlos Ortiz-de-Solorzano, Peter Ellmark, Sara Fritzell, Gabriela Hernandez-Hoyos, Michelle Hase Nelson, María Carmen Ochoa, Elixabet Bolaños, Doina Cuculescu, Patricia Jaúregui, Sandra Sanchez-Gregorio, Iñaki Etxeberria, María E. Rodriguez-Ruiz, Miguel F. Sanmamed, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero

    Published in Nature Communications (2021-12-01)
    Get full text
    Article


Search Tools: